RxDoctor Payments Data

Rosibel Guzman

Psychiatric/Mental Health · Danvers, MANPI 1801363197

Payments from drug & device makers

$2,925in general payments, 2019–2025

Across 181 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$895
  • Lundbeck LLC$538
  • Teva Pharmaceuticals USA, Inc.$314
  • Corium, LLC$274
  • Otsuka America Pharmaceutical, Inc.$247
  • Axsome Therapeutics, Inc.$212
  • plus $444 from 5 others

What the payments were for

  • Food & beverage$2,925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,925 in reported general payments places this provider in the 90th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$9,949
Medicare patients
50
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl31$54,832
Invega SustennaPaliperidone Palmitate12$45,825
RexultiBrexpiprazole16$27,640
Quetiapine Fumarate144$3,679
Buspirone Hcl81$2,331
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine23$1,976
Perphenazine24$1,826
Mirtazapine87$1,822
Trazodone Hcl131$1,633
Venlafaxine Hcl ErVenlafaxine Hcl98$1,597
Clonazepam147$1,497
Vilazodone Hcl18$1,300
Desvenlafaxine Succinate ErDesvenlafaxine Succinate50$1,278
Divalproex Sodium17$1,051
Bupropion XlBupropion Hcl27$792

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$895$54,83231 claims
Otsuka America Pharmaceutical, Inc.Rexulti$247$27,64016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

Other psychiatric/mental health in Danvers

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →